Texas Oncology-Fort Worth Cancer Center — Fort Worth, Texas

Texas Oncology-Fort Worth Cancer Center is a clinical research site located in Fort Worth, Texas, United States 76104.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Texas Oncology-Fort Worth Cancer Center has participated in 9 clinical trials with 5 currently active.

Therapeutic areas: Advanced Solid Tumor, Ovarian Cancer, Platinum-resistant Ovarian Cancer.

Sponsors: Janssen Research & Development, LLC, K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc, Kartos Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Texas Oncology-Fort Worth Cancer Center?

Texas Oncology-Fort Worth Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Texas Oncology-Fort Worth Cancer Center conducted?

Texas Oncology-Fort Worth Cancer Center has 9 clinical trials on record, with 5 currently active. Their work covers Advanced Solid Tumor, Ovarian Cancer, Platinum-resistant Ovarian Cancer.

Is Texas Oncology-Fort Worth Cancer Center accredited by Crixeo Health?

Yes — Texas Oncology-Fort Worth Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Texas Oncology-Fort Worth Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.